112 related articles for article (PubMed ID: 7767837)
1. Prevention of ovariectomy osteopenia in rats after vaginal administration of Hyaff 11 microspheres containing salmon calcitonin.
Bonucci E; Ballanti P; Ramires PA; Richardson JL; Benedetti LM
Calcif Tissue Int; 1995 Apr; 56(4):274-9. PubMed ID: 7767837
[TBL] [Abstract][Full Text] [Related]
2. Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin.
DeLuca PP; Dani BA
AAPS PharmSci; 2001; 3(4):E27. PubMed ID: 12049490
[TBL] [Abstract][Full Text] [Related]
3. Effect of Cissus quadrangularis Linn on the development of osteopenia induced by ovariectomy in rats.
Potu BK; Nampurath GK; Rao MS; Bhat KM
Clin Ter; 2011; 162(4):307-12. PubMed ID: 21912817
[TBL] [Abstract][Full Text] [Related]
4. An acute and focal osteopenia model using ovariectomized rats: a rapid detection of the protective effect of salmon calcitonin.
Nakamuta H; Sasaki M; Ichikawa M; Koida M
Biol Pharm Bull; 1993 Mar; 16(3):325-7. PubMed ID: 8364484
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.
Qi H; Li M; Wronski TJ
J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319
[TBL] [Abstract][Full Text] [Related]
6. Histomorphometrical evaluation of anti-osteopenic effect of nasal salmon calcitonin in a type 1 osteoporotic model of rats.
Nitta T; Hoshino T; Koida M; Nakamuta H
Biol Pharm Bull; 1996 Feb; 19(2):214-6. PubMed ID: 8850308
[TBL] [Abstract][Full Text] [Related]
7. Bone anabolic effects of PTH(1-34) and salmon calcitonin in ovariectomy- and ovariectomy-steroid-induced osteopenic rats: a histomorphometric and biomechanical study.
Fukushima T; Nitta T; Furuichi H; Izumo N; Fukuyama T; Nakamuta H; Koida M
Jpn J Pharmacol; 2000 Mar; 82(3):240-6. PubMed ID: 10887955
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin.
Nitta T; Fukushima T; Nakamuta H; Koida M
Jpn J Pharmacol; 1999 Mar; 79(3):379-86. PubMed ID: 10230867
[TBL] [Abstract][Full Text] [Related]
9. A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells.
Dani BA; Raiche AT; Puleo DA; DeLuca PP
AAPS PharmSciTech; 2002; 3(3):E21. PubMed ID: 12916936
[TBL] [Abstract][Full Text] [Related]
10. Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
Okubo R; Sanada LS; Castania VA; Louzada MJ; de Paula FJ; Maffulli N; Shimano AC
Osteoporos Int; 2017 Apr; 28(4):1461-1471. PubMed ID: 28124728
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin.
Morimoto K; Katsumata H; Yabuta T; Iwanaga K; Kakemi M; Tabata Y; Ikada Y
Eur J Pharm Sci; 2001 May; 13(2):179-85. PubMed ID: 11297902
[TBL] [Abstract][Full Text] [Related]
12. Skeletal effects of calcitonin treatment and withdrawal in ovariectomized rats.
Shen Y; Li M; Wronski TJ
Calcif Tissue Int; 1996 Apr; 58(4):263-7. PubMed ID: 8661958
[TBL] [Abstract][Full Text] [Related]
13. Anti-osteopenic effect of nasal salmon calcitonin in type 1 osteoporotic rats: comparison with subcutaneous dosing.
Ichikawa M; Nakamuta H; Hoshino T; Ogawa Y; Koida M
Biol Pharm Bull; 1994 Jul; 17(7):911-3. PubMed ID: 8000375
[TBL] [Abstract][Full Text] [Related]
14. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
[TBL] [Abstract][Full Text] [Related]
15. Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover.
Nielsen RH; Bay-Jensen AC; Byrjalsen I; Karsdal MA
Osteoarthritis Cartilage; 2011 Apr; 19(4):466-73. PubMed ID: 21251986
[TBL] [Abstract][Full Text] [Related]
16. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats.
Wronski TJ; Cintrón M; Doherty AL; Dann LM
Endocrinology; 1988 Aug; 123(2):681-6. PubMed ID: 3396505
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
[TBL] [Abstract][Full Text] [Related]
18. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
[TBL] [Abstract][Full Text] [Related]
19. Salmon Calcitonin Attenuates Degenerative Changes in Cartilage and Subchondral Bone in Lumbar Facet Joint in an Experimental Rat Model.
Gou Y; Tian F; Kong Q; Chen T; Li H; Lv Q; Zhang L
Med Sci Monit; 2018 May; 24():2849-2857. PubMed ID: 29748528
[TBL] [Abstract][Full Text] [Related]
20. Reversible lipidization for the oral delivery of salmon calcitonin.
Wang J; Chow D; Heiati H; Shen WC
J Control Release; 2003 Mar; 88(3):369-80. PubMed ID: 12644363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
